Phase 3 Clinical Study for the Treatment of Cold Sore
Public ClinicalTrials.gov record NCT00769314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-Blind, Single Dose, One-Day Early Administration, Multicentre Study Comparing the Efficacy and Safety of Acyclovir Lauriad® 50 mg Muco-adhesive Buccal Tablet to Matching Placebo, in the Treatment of Herpes Labialis in Immunocompetent Patients.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To demonstrate the efficacy of a single dose of acyclovir Lauriad® 50mg muco-adhesive buccal tablet versus a single dose of matching placebo on the primary vesicular lesion of cold sore.
Study identification
- NCT ID
- NCT00769314
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,727 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2007 (Type not available)
- Primary completion
- Nov 2008 (Actual)
- Completion
- Aug 2009 (Actual)
- Last update posted
- Dec 21, 2012
2007 – 2009
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research, Inc., | Scottsdale | Arizona | 85251 | — |
| Radiant Research, Inc., | Tucson | Arizona | 85710 | — |
| Dermatology Private Practice | San Francisco | California | 94114 | — |
| Front Range Clinical Research | Wheat Ridge | Colorado | 80033 | — |
| St. Luke's Family Health, | Meridian | Idaho | 83642 | — |
| Clinvest, a Division of Banyan Group, Inc., | Springfield | Missouri | 65807 | — |
| Rochester Clinical Research, Inc., | Rochester | New York | 14609 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794-8091 | — |
| Center for Clinical Studies | Houston | Texas | 77030 | — |
| Center for Clinical Studies, Ltd., LLP. | Houston | Texas | 77058 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00769314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2012 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00769314 live on ClinicalTrials.gov.